Test performance characteristics of quantitative nucleic acid testing for polyomaviruses in kidney and kidney-pancreas transplant recipients

scientific article published on 17 August 2013

Test performance characteristics of quantitative nucleic acid testing for polyomaviruses in kidney and kidney-pancreas transplant recipients is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/CTR.12195
P698PubMed publication ID23952788

P50authorGermaine WongQ60227954
Jonathan CraigQ38591193
Angela WebsterQ37834876
P2093author name stringD E Dwyer
P O'Connell
R M Turner
J R Chapman
S D Roger
T M M Myint
B J Nankivell
K Kable
N B Cross
N Jeoffreys
P2860cites workManagement of polyomavirus-associated nephropathy in renal transplant recipientsQ38003050
Evaluating diagnostic tests with imperfect standardsQ38140577
Systematic screening of BK virus by real-time PCR prevents BK virus associated nephropathy in renal transplant recipientsQ30224990
An OPTN analysis of national registry data on treatment of BK virus allograft nephropathy in the United StatesQ33427765
Assessment of diagnostic tests when disease verification is subject to selection biasQ34272301
Polyomavirus disease in renal transplantation: review of pathological findings and diagnostic methodsQ34470611
Polyomavirus BK nephropathy: a (re-)emerging complication in renal transplantationQ34719108
Polyomavirus BK.Q35548648
Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendationsQ36136619
Polyomavirus-associated nephropathy in renal transplantation: critical issues of screening and managementQ36454167
Correlates of quantitative measurement of BK polyomavirus (BKV) DNA with clinical course of BKV infection in renal transplant patientsQ36598800
Marked variability of BK virus load measurement using quantitative real-time PCR among commonly used assaysQ36845374
Quantitation of BK virus DNA for diagnosis of BK virus-associated nephropathy in renal transplant recipientsQ36966167
Complications post renal transplantation: literature focus on BK virus nephropathy and diagnostic tools actually availableQ37100327
Risk factors for polyoma virus nephropathyQ37102082
Monitoring of BK viral load in renal allograft recipients by real-time PCR assaysQ37679405
Banff 07 classification of renal allograft pathology: updates and future directionsQ40121163
Factors contributing to variability of quantitative viral PCR results in proficiency testing samples: a multivariate analysisQ40599317
Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipientsQ44104230
Influence of surveillance renal allograft biopsy on diagnosis and prognosis of polyomavirus-associated nephropathyQ44503856
Clinical usefulness of BK virus plasma quantitative PCR to prevent BK virus associated nephropathyQ44763558
Improved outcome of polyoma virus allograft nephropathy with early biopsyQ44863789
Histological patterns of polyomavirus nephropathy: correlation with graft outcome and viral loadQ45171040
A prospective longitudinal study of BK virus infection in 120 Czech renal transplant recipientsQ45366195
Monthly screening for BK viremia is an effective strategy to prevent BK virus nephropathy in renal transplant recipientsQ45368576
Screening to prevent polyoma virus nephropathy in kidney transplantation: a cost analysisQ45383228
Monitoring of BK virus replication in the first year following renal transplantationQ45394812
Measurements of global cell-mediated immunity in renal transplant recipients with BK virus reactivationQ45396476
Screening to prevent polyoma virus nephropathy: a medical decision analysisQ45423889
Quantitation of BK virus load in serum for the diagnosis of BK virus-associated nephropathy in renal transplant recipientsQ45737444
Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative.Q52947167
Screening for polyomavirus associated nephropathy in renal transplantation with blood viral load measurement.Q54475710
Factors influencing viral clearing and renal function during polyomavirus BK-associated nephropathy after renal transplantation.Q54494484
Quantification and identification of polyomavirus DNA in blood and urine of renal transplant recipients.Q54579991
Protocol biopsy of the stable renal transplant: a multicenter study of methods and complication ratesQ58378360
Diagnostic accuracy of blood qualitative nucleic acid testing for polyomavirus-associated nephropathy in kidney recipientsQ59167652
The Banff 97 working classification of renal allograft pathologyQ59314413
P433issue5
P921main subjectpancreasQ9618
P304page(s)E571-9
P577publication date2013-08-17
P1433published inClinical TransplantationQ15754920
P1476titleTest performance characteristics of quantitative nucleic acid testing for polyomaviruses in kidney and kidney-pancreas transplant recipients
P478volume27

Reverse relations

Q28070240BK nephropathy in the native kidneys of patients with organ transplants: Clinical spectrum of BK infectioncites workP2860

Search more.